Login to Your Account



Other News To Note


Tuesday, April 9, 2013

• Resverlogix Corp., of Calgary, Alberta, said its board approved a proposal to spin out its subsidiary, RVX Therapeutics Inc., which will focus on drug research and development by leveraging its epigenetics platform.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription